ATF3/AP-1信号通路激活介导P2X3诱导的子宫内膜异位症疼痛
该研究在大鼠子宫内膜异位症模型中探讨P2X3在疼痛中的作用。结果发现,ATF3/AP-1通路激活上调背根神经节P2X3表达,参与痛觉过敏;CSOSA/LPs/SP600125递送系统可减轻痛觉过敏、缩小病灶并下调P2X3。
要点
- P2X3在子宫内膜异位症病灶和背根神经节中表达升高,与痛觉过敏严重程度正相关。
- ADP通过ATF3结合P2X3启动子上调P2X3表达,SP600125可抑制该过程。
- CSOSA/LPs/SP600125递送系统可靶向病灶,缓解大鼠子宫内膜异位症疼痛。
核心结论
- P2X3在背根神经节的上调通过ATF3/AP-1通路参与子宫内膜异位症相关痛觉过敏。
- 靶向P2X3受体可能为子宫内膜异位症疼痛提供新的治疗途径。
研究设计与样本
- 研究采用大鼠子宫内膜异位症模型,检测痛觉过敏程度、内源性ATP含量及病灶和背根神经节中P2X3表达水平。
- 在背根神经节细胞中,用ADP刺激后检测ATF3和P2X3表达,并用ATF3质粒和siRNA探究ATF3对ADP诱导P2X3上调的作用。
- 采用染色质免疫沉淀和荧光素酶试验评估ATF与P2X3启动子的结合活性。
- 将JNK抑制剂SP600125包裹于CSOSA/LPs递送系统,测试其对ADP诱导背根神经节细胞P2X3上调和大鼠子宫内膜异位症痛觉过敏的抑制作用。
主要发现
- 子宫内膜异位症大鼠模型病灶和背根神经节组织中内源性ATP浓度和P2X3表达水平显著升高,且与痛觉过敏严重程度正相关。
- 在背根神经节细胞中,ADP刺激升高P2X3表达,而用siRNA阻断ATF3或用SP600125可显著抑制该上调。
- 染色质免疫沉淀和荧光素酶试验显示ADP增加ATF3与P2X3启动子的结合,导致P2X3表达水平升高。
- CSOSA/LPs/SP600125递送系统可使药物有效浓集于子宫内膜异位病灶,减轻痛觉过敏、缩小病灶并下调P2X3表达。
临床怎么用
- 本研究提示ATP-P2X3轴参与子宫内膜异位症疼痛,P2X3受体可作为潜在治疗靶点。
- CSOSA/LPs/SP600125递送系统在动物模型中显示靶向病灶并缓解疼痛的效果,但尚未进入临床。
局限性
- 子宫内膜异位症引起的P2X3敏感性和功能变化需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does P2X ligand-gated ion channel 3 (P2X3) play a role in endometriosis pain? SUMMARY ANSWER: Upregulation of P2X3 in dorsal root ganglia (DRG) tissues via the activating transcription factor 3 (ATF3)/activator protein (AP)-1 pathway contributed to endometriosis-associated hyperalgesia, which could be attenuated by the chitosan oligosaccharide stearic acid (CSOSA)/liposomes (LPs)/SP600125 delivery system. WHAT IS KNOWN ALREADY: Infiltrating nerve fibers and elevated nociceptors in endometriotic lesions are associated with endometriosis pain. P2X3 has been demonstrated to play an important role in neuropathic pain. STUDY DESIGN, SIZE, DURATION: A rat model of endometriosis was used to investigate the signaling pathways involved in P2X3-induced pain. PARTICIPANTS/MATERIALS, SETTING, METHODS: Degrees of hyperalgesia, endogenous adenosine 5'-triphosphate (ATP) contents and P2X3 expression levels in endometriotic lesions and DRG tissues were detected in a rat model of endometriosis. The expression levels of ATF3 and P2X3 were measured using qRT-PCR, western blot analysis and immunofluorescence analysis after adenosine 5'-diphosphate (ADP) exposure in DRG cells. Plasmids encoding ATF3 and its siRNA were used to investigate the role of ATF3 on ADP-induced P2X3 upregulation. The activity of ATF binding to the P2X3 promoter was evaluated by using chromatin immunoprecipitation (CHIP) and luciferase assays. SP600125, an inhibitor of c-JUN N-terminal kinase, was wrapped in CSOSA/LPs delivery system and its inhibitory effects on ADP-induced upregulation of P2X3 in DRG cells and endometriosis-induced hyperalgesia in rats were tested. MAIN RESULTS AND THE ROLE OF CHANCE: The concentrations of endogenous ATP and expression levels of P2X3 were significantly increased in both endometriotic lesions and DRG tissues in endometriosis rat models and were found to be positively correlated with the severity of hyperalgesia. In DRG cells, P2X3 expression levels were elevated by ADP stimulation, but dramatically inhibited by blocking ATF3 with its siRNA and SP600125. CHIP and luciferase assay showed that ADP increased the binding of ATF3 to the P2X3 promoter, resulting in an increase in P2X3 expression levels. In the CSOSA/LPs/SP600125 delivery system, the drug could be effectively concentrated in endometriotic lesions, and it could alleviate endometriosis-induced hyperalgesia, reduce the size of endometriotic lesions and attenuate upregulated P2X3 expression levels in endometriosis rat models. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Changes in the sensitivity and function of P2X3 caused by endometriosis need to be further investigated. WIDER IMPLICATIONS OF THE FINDINGS: This study indicates that ATP and the P2X3 receptor are involved in endometriosis pain, thus providing a novel therapeutic approach for the treatment of endometriosis pain by targeting the P2X3 receptor. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by National Key R&D Program of China (Grant No. 2017YFC1001202) and National Natural Science Foundation of China (Grant Nos. 81974225, 81671429 and 81471433). There are no competing interests.
引用
- Ding S, Yu Q, Wang J, et al. Activation of ATF3/AP-1 signaling pathway is required for P2X3-induced endometriosis pain. Hum Reprod. 2020. PMID: 32303740. doi:10.1093/humrep/deaa061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。